Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2022 |
Income Tax Disclosure [Abstract] |
|
Schedule of Components of Income Tax Benefit |
The components of the income tax expense (benefit) for continuing operations are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2022 |
|
2021 |
|
2020 |
Current expense (benefit): |
|
|
|
|
|
Federal |
$ |
10,097 |
|
|
$ |
460 |
|
|
$ |
10,820 |
|
State |
193 |
|
|
(22) |
|
|
541 |
|
Foreign |
452 |
|
|
— |
|
|
23 |
|
|
10,742 |
|
|
438 |
|
|
11,384 |
|
Deferred expense (benefit): |
|
|
|
|
|
Federal |
(3,656) |
|
|
(2,901) |
|
|
(13,456) |
|
State |
34,144 |
|
|
(1,685) |
|
|
(3,234) |
|
|
30,488 |
|
|
(4,586) |
|
|
(16,690) |
|
Total income tax expense (benefit) |
$ |
41,230 |
|
|
$ |
(4,148) |
|
|
$ |
(5,306) |
|
|
Schedule of Effective Income Tax Rate Reconciliation |
A reconciliation of income tax expense (benefit) from continuing operations to the amount computed by applying the statutory federal income tax rate to the net income (loss) from continuing operations is summarized as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2022 |
|
2021 |
|
2020 |
Tax at federal statutory rate |
$ |
7,562 |
|
|
$ |
15,163 |
|
|
$ |
272 |
|
State, net of federal benefit |
264 |
|
|
(82) |
|
|
(1,231) |
|
FDII |
(2,395) |
|
|
(637) |
|
|
(1,652) |
|
Rate change for changes in federal, foreign or state law |
(535) |
|
|
(7,963) |
|
|
(164) |
|
Change in uncertain tax positions |
(158) |
|
|
480 |
|
|
(673) |
|
Sale of Vernalis R&D |
— |
|
|
— |
|
|
127,372 |
|
Contingent liabilities |
15 |
|
|
(7,993) |
|
|
(266) |
|
Foreign tax differential on income/loss of foreign subsidiaries |
103 |
|
|
(114) |
|
|
(3,839) |
|
Research and development credits |
256 |
|
|
(1,628) |
|
|
(168) |
|
Debt repurchases |
626 |
|
|
— |
|
|
— |
|
Subpart F income |
853 |
|
|
1,392 |
|
|
25 |
|
Share-based compensation |
1,279 |
|
|
(12,080) |
|
|
(623) |
|
Provision to return adjustments |
2,232 |
|
|
(1,347) |
|
|
(5,920) |
|
Officer compensation |
5,869 |
|
|
3,239 |
|
|
2,410 |
|
Change in valuation allowance |
24,799 |
|
|
11,245 |
|
|
(121,864) |
|
Other |
460 |
|
|
(3,823) |
|
|
1,015 |
|
|
$ |
41,230 |
|
|
$ |
(4,148) |
|
|
$ |
(5,306) |
|
|
Schedule of Deferred Tax Assets and Liabilities |
Deferred tax assets (liabilities) are comprised of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
2022 |
|
2021 |
|
(in thousands) |
Deferred tax assets: |
|
|
|
Net operating loss carryforwards |
$ |
53,960 |
|
|
$ |
63,471 |
|
Research credit carryforwards |
26,309 |
|
|
26,908 |
|
Stock compensation |
11,158 |
|
|
9,743 |
|
Other |
19,542 |
|
|
12,989 |
|
|
110,969 |
|
|
113,111 |
|
Valuation allowance for deferred tax assets |
(57,472) |
|
|
(35,931) |
|
Net deferred tax assets |
$ |
53,497 |
|
|
$ |
77,180 |
|
|
|
|
|
Deferred tax liabilities: |
|
|
|
Identified intangibles |
(64,696) |
|
|
(66,848) |
|
Other |
(10,886) |
|
|
(5,459) |
|
Net deferred tax liabilities |
$ |
(75,582) |
|
|
$ |
(72,307) |
|
|
|
|
|
Deferred income taxes, net |
$ |
(22,085) |
|
|
$ |
4,873 |
|
|
Schedule of Unrecognized Tax Benefits |
A reconciliation of the amount of unrecognized tax benefits at December 31, 2022, 2021 and 2020 is as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
2022 |
|
2021 |
|
2020 |
Balance at beginning of year |
$ |
29,550 |
|
|
$ |
31,619 |
|
|
$ |
28,647 |
|
Additions based on tax positions related to the current year |
58 |
|
|
252 |
|
|
3,911 |
|
Additions for tax positions of prior years |
— |
|
|
751 |
|
|
15 |
|
Reductions for tax positions of prior years |
(512) |
|
|
(3,072) |
|
|
(954) |
|
Balance at end of year |
$ |
29,096 |
|
|
$ |
29,550 |
|
|
$ |
31,619 |
|
|